Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle Group Acquires Unchained Labs for $435 Million

Posted in Life Sciences Investing

The Carlyle Group has announced it has agreed to acquire Unchained Labs for $435 million.

Unchained Labs, based in Pleasanton, Calif., is a producer of life sciences tools. Founded in 2015, the company focuses on solving problems for biologics and gene therapy researchers.

The Carlyle Group, with its U.S. headquarters in Washington, D.C., is a global investment firm that deploys private capital across three business segments: global private equity, global credit and investment solutions. Founded in 1987, the firm targets companies in healthcare and many other industries.

The Carlyle Group is acquiring Unchained Labs from Novo Holdings, Canaan Partners and TPG Biotech.

The transaction is expected to close in Q2 2021.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.